Clinical Trial Update: Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab) [Phase 4]

View source ↗

Summary

Phase 4 trial results for mepolizumab in aspirin-induced asthma and chronic rhinosinusitis with nasal polyps have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspirin-exacerbated Respiratory Disease
• Asthma
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Asthma, Aspirin-Induced, Chronic Rhinosinusitis With Nasal Polyps | Phase 4 | Status: COMPLETED | Results posted: 2026-03-24